Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Simvastatin in patients with progressive multiple sclerosis--Authors' reply.
Neurosarcoidosis as an MS Mimic: The trials and tribulations of making a diagnosis.
Paroxetine-Related Adult-Onset Tic Disorder: A Presentation of Primary Progressive Multiple Sclerosis.
Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies.
Stretching the limbs? Tonic spasms in multiple sclerosis.
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis.
Progressive multifocal leukoencephalopathy: cavitary white matter lesions.
EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor Occupancy.
T-cell homeostasis in pediatric multiple sclerosis: Old cells in young patients.
Monoclonal Antibodies in Treatment of Multiple Sclerosis.
Presence of aberrant V<formula>_{H}</formula>6 domains in anti-interferon-γ autoantibodies in multiple sclerosis.
Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells.
A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis.
Does helminth activation of toll-like receptors modulate immune response in multiple sclerosis patients?
Prodrugs of fumarate esters for the treatment of psoriasis and multiple sclerosis-a computational approach.
Chondroitin 6-O-sulfate ameliorates experimental autoimmune encephalomyelitis.
Toll like receptor 2 and 4 expression in peripheral blood mononuclear cells of multiple sclerosis patients.
Interactions between microglia and T cells in multiple sclerosis pathobiology.
Murine experimental autoimmune encephalomyelitis is diminished by treatment with the angiogenesis inhibitors b20-4.1.1 and angiostatin (k1-3).
Assessment of ovarian reserve and Doppler characteristics in patients with multiple sclerosis using immunomodulating drugs.
Nogo Receptor Inhibition Enhances Functional Recovery following Lysolecithin-Induced Demyelination in Mouse Optic Chiasm.
Cohort Study Comparing the Berg Balance Scale and the Mini-BESTest in Ambulatory People With Multiple Sclerosis.
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis.
(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis.
Pages
« first
‹ previous
…
361
362
363
364
365
366
367
368
369
…
next ›
last »